3-(2-carboxypiperazin-4-yl)propyl-1-phosphonic acid has been researched along with evans blue in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cobanoğlu, S; Görgülü, A; Kiriş, T; Küçük, M; Türkoğlu, U; Unal, F | 1 |
| Miyagi, Y; Zhang, JH | 1 |
2 other study(ies) available for 3-(2-carboxypiperazin-4-yl)propyl-1-phosphonic acid and evans blue
| Article | Year |
|---|---|
Protective effect of the N-methyl-D-aspartate receptor antagonists, MK-801 and CPP on cold-induced brain oedema.
Topics: Analysis of Variance; Animals; Blood-Brain Barrier; Body Water; Brain Edema; Cold Temperature; Disease Models, Animal; Dizocilpine Maleate; Evans Blue; Excitatory Amino Acid Antagonists; Male; Neuroprotective Agents; Piperazines; Rats; Rats, Sprague-Dawley; Specific Gravity | 1999 |
Aalpha,beta-methylene ATP enhances P2Y4 contraction of rabbit basilar artery.
Topics: Adenosine Triphosphate; Animals; Basilar Artery; Coloring Agents; Endothelium, Vascular; Evans Blue; In Vitro Techniques; Isometric Contraction; Muscle, Smooth, Vascular; Nucleotidases; Piperazines; Potassium Chloride; Purinergic P2 Receptor Agonists; Rabbits; Receptors, Purinergic P2; Uridine Triphosphate | 2004 |